104 related articles for article (PubMed ID: 10456236)
1. A rabbit model of proliferative vitreoretinopathy induced by injection of astrocytic cultures.
Yew DT; Yi X; Chan WY; Lam WK
Cell Mol Neurobiol; 1999 Dec; 19(6):759-73. PubMed ID: 10456236
[TBL] [Abstract][Full Text] [Related]
2. Preretinal membrane formation in rabbit eyes after intravitreal transplantation of cultured astrocytes.
Mishima N; Yamashita H; Ishii Y; Hori S
Jpn J Ophthalmol; 1989; 33(4):501-18. PubMed ID: 2696800
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of periocular corticosteroids in experimental proliferative vitreoretinopathy.
Rubsamen PE; Cousins SW
Retina; 1997; 17(1):44-50. PubMed ID: 9051842
[TBL] [Abstract][Full Text] [Related]
4. Inverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
Ogata N; Nishikawa M; Nishimura T; Mitsuma Y; Matsumura M
Am J Ophthalmol; 2002 Jun; 133(6):851-2. PubMed ID: 12036691
[TBL] [Abstract][Full Text] [Related]
5. EIU in the rat promotes the potential of syngeneic retinal cells injected into the vitreous cavity to induce PVR.
Behar-Cohen FF; Thillaye-Goldenberg B; de Bizemont T; Savoldelli M; Chauvaud D; de Kozak Y
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3915-24. PubMed ID: 11053294
[TBL] [Abstract][Full Text] [Related]
6. Transient coexpression of nestin, GFAP, and vascular endothelial growth factor in mature reactive astroglia following neural grafting or brain wounds.
Krum JM; Rosenstein JM
Exp Neurol; 1999 Dec; 160(2):348-60. PubMed ID: 10619552
[TBL] [Abstract][Full Text] [Related]
7. Experimental tractional retinal detachment: an immunohistochemical study.
Basmak H; Isiksoy S; Topbas S; Artan S; Yurdakul S
Eur J Ophthalmol; 1998; 8(2):112-7. PubMed ID: 9673481
[TBL] [Abstract][Full Text] [Related]
8. [Concentration of vascular endothelial growth factor within the subretinal space and vitreous fluid in rhegmatogenous retinal detachment].
Moromizato Y; Hayashi H; Kato H; Ozaki H; Oshima K
Nippon Ganka Gakkai Zasshi; 1997 Jun; 101(6):498-502. PubMed ID: 9209137
[TBL] [Abstract][Full Text] [Related]
9. Activation of neural progenitor cells in human eyes with proliferative vitreoretinopathy.
Johnsen EO; Frøen RC; Albert R; Omdal BK; Sarang Z; Berta A; Nicolaissen B; Petrovski G; Moe MC
Exp Eye Res; 2012 May; 98():28-36. PubMed ID: 22465407
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom.
Yang CH; Huang TF; Liu KR; Chen MS; Hung PT
Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):843-54. PubMed ID: 8603869
[TBL] [Abstract][Full Text] [Related]
11. Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy.
Mandava N; Blackburn P; Paul DB; Wilson MW; Read SB; Alspaugh E; Tritz R; Barber JR; Robbins JM; Kruse CA
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3338-48. PubMed ID: 12356843
[TBL] [Abstract][Full Text] [Related]
12. Concentration of vascular endothelial growth factor in the subretinal fluid of retinal detachment.
Su CY; Chen MT; Wu WS; Wu WC
J Ocul Pharmacol Ther; 2000 Oct; 16(5):463-9. PubMed ID: 11110038
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antiproliferative effects of the somatostatin analogue somatuline in a rabbit model of traction retinal detachment.
Baudouin C; Imbert F; Ettaiche M; Gastaud P
Fundam Clin Pharmacol; 1995; 9(4):357-65. PubMed ID: 8566935
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical study of retinal Müller cell response in experimental epiretinal membrane formation].
Kono T; Kato H; Oshima K
Nippon Ganka Gakkai Zasshi; 1998 Jan; 102(1):22-7. PubMed ID: 9489366
[TBL] [Abstract][Full Text] [Related]
15. Vitreous concentrations of TPA and plasminogen activator inhibitor are associated with VEGF in proliferative diabetic vitreoretinopathy.
Hattenbach LO; Allers A; Gümbel HO; Scharrer I; Koch FH
Retina; 1999; 19(5):383-9. PubMed ID: 10546932
[TBL] [Abstract][Full Text] [Related]
16. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the integrin alpha5beta1 antagonist JSM6427 in proliferative vitreoretinopathy using in vitro assays and a rabbit model of retinal detachment.
Zahn G; Volk K; Lewis GP; Vossmeyer D; Stragies R; Heier JS; Daniel PE; Adamis AP; Chapin EA; Fisher SK; Holz FG; Löffler KU; Knolle J
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1028-35. PubMed ID: 19815730
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression.
Zhang X; Barile G; Chang S; Hays A; Pachydaki S; Schiff W; Sparrow J
Curr Eye Res; 2005 May; 30(5):395-403. PubMed ID: 16020270
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor (vascular permeability factor) expression in injured rat brain.
Papavassiliou E; Gogate N; Proescholdt M; Heiss JD; Walbridge S; Edwards NA; Oldfield EH; Merrill MJ
J Neurosci Res; 1997 Aug; 49(4):451-60. PubMed ID: 9285521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
